BriaCell Therapeutics Corp. (BCTXW) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en West Vancouver, BC, Canada. El CEO actual es William V. Williams.
BCTXW tiene fecha de IPO 2012-08-13, 16 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $1.7K.
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
